SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Sun Pharma Advanced Research Company

BSE: 532872|NSE: SPARC|ISIN: INE232I01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 23, 15:58
317.40
3.05 (0.97%)
VOLUME 59,166
LIVE
NSE
Feb 23, 15:59
318.20
3.6 (1.14%)
VOLUME 220,343
Announcements on Sun Pharma Adv

24th-Feb-2017 19:06Source: BSE

Sun Pharma Adv- Receipt of demand notice under section 156 of the Income Tax Act, 1961

Sun Pharma Advanced Research Company Ltd has informed BSE that the Company is in receipt of a 'Demand Notice' under section 156 of the Income Tax, 1961 demanding the payment by the Company of a sum of...

1st-Feb-2017 16:11Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has informed the Exchange that Mr. Chetan Rajpara, CFO has been authorised severally to determine materiality of an event or information and for making dis...

1st-Feb-2017 15:57Source: BSE

Sun Pharma Adv- Change in Authorised KMP to determine materiality of an event or information

Sun Pharma Advanced Research Company Ltd has informed BSE regarding "Change in Authorised KMP to determine materiality of an event or information."

27th-Jan-2017 14:03Source: BSE

Sun Pharma Adv- Outcome of Board Meeting

Sun Pharma Advanced Research Company Ltd has informed BSE about Outcome of Board Meeting held on January 27, 2017.

27th-Jan-2017 13:55Source: BSE

Sun Pharma Adv- Announces Q3 results (Standalone) & Limited Review Report (Standalone) for the Quarter ended December 31, 2016

Sun Pharma Advanced Research Company Ltd has announced the following Unaudited Standalone results for the quarter ended December 31, 2016:

The Company has posted a net loss of Rs. (663.30) mill...

23rd-Jan-2017 16:47Source: BSE

Sun Pharma Adv- Shareholding for the Period Ended December 31, 2016

Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly

14th-Jan-2017 11:57Source: BSE

Sun Pharma Adv- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016

Sun Pharma Advanced Research Company Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulatio...

11th-Jan-2017 13:25Source: BSE

Sun Pharma Adv- Q3 results on Jan 27, 2017

Sun Pharma Advanced Research Company Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 27, 2017, inter alia, to consider and take on record, the un-a...

11th-Jan-2017 13:13Source: BSE

Sun Pharma Adv- Q3 results on Jan 27, 2016

Sun Pharma Advanced Research Company Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 27, 2017, inter alia, to consider and take on record, the un-a...

22nd-Dec-2016 09:17Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has informed the Exchange that the Company has received a Complete Response Letter (CRL) from the USFDA for the New Drug Application (NDA) for XelprosTM, L...

1 2 3 4 5 Next >>
Quick Links for Sun Pharma Advanced Research Company
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.